Home>
US Stocks>
Abeona Therapeutics Inc.

Abeona Therapeutics Inc. share price today

(ABEO)

Abeona Therapeutics Inc. share price is $6.02 & ₹509.55 as on 6 Dec 2024, 2.30 'hrs' IST

$6.02

Market is closed - opens 8 PM, 06 Dec 2024

View live Abeona Therapeutics Inc. share price in Dollar and Rupees. Guide to invest in Abeona Therapeutics Inc. from India. Also see the sentimental analysis on Indian investors investing in Abeona Therapeutics Inc.. Get details on the Indian mutual funds that are investing in Abeona Therapeutics Inc.. Get Analyst recommendations and forecasts along with all the Abeona Therapeutics Inc.'s financials.

Abeona Therapeutics Inc. share price movements

$5.94
$6.06
$6.02
1.33%
Downside
Day's Volatility :1.9%
Upside
0.58%
$3.05
$9.01
$6.02
49.34%
Downside
52 Weeks Volatility :66.15%
Upside
33.19%

Abeona Therapeutics Inc. Returns

Period	Abeona Therapeutics Inc.	Russel 2000	Index (Russel 2000)
3 Months	8.38%	0.0%	0.0%
6 Months	40.87%	0.0%	0.0%
1 Year	26.63%	0.0%	0.0%
3 Years	-62.06%	-19.7%	-19.7%

Abeona Therapeutics Inc. Key Statistics

in dollars & INR

Previous Close	$6.01
Open	$6.0
Today's High	$6.055
Today's Low	$5.94
Market Capitalization	$261.3M
Today's Volume	$212.6K
52 Week High	$9.01
52 Week Low	$3.05
Revenue TTM	$0.0
EBITDA	$-54.7M
Earnings Per Share (EPS)	$-2.02
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-127.38%

How to invest in Abeona Therapeutics Inc. from India?

It is very easy for Indian residents to invest directly in Abeona Therapeutics Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abeona Therapeutics Inc. stock in both rupees (INR) and dollars (USD). Search for Abeona Therapeutics Inc. or ABEO on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abeona Therapeutics Inc. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abeona Therapeutics Inc. shares which would translate to 0.141 fractional shares of Abeona Therapeutics Inc. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Abeona Therapeutics Inc.

80%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Abeona Therapeutics Inc. on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 80% more investors are searching Abeona Therapeutics Inc. in the last 30 days versus the previous period.

Global Institutional Holdings in Abeona Therapeutics Inc.

Suvretta Capital Management, LLC
8.48%
Nantahala Capital Management, LLC
7.90%
Adage Capital Partners Gp LLC
7.48%
Millennium Management LLC
5.29%
Vanguard Group Inc
4.62%
Vivo Capital, LLC
4.24%

Analyst Recommendation on Abeona Therapeutics Inc.

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Abeona Therapeutics Inc.(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Abeona Therapeutics Inc.

What analysts predicted

Upside of 178.24%

Current:

$6.02

Target:

$16.75

Insights on Abeona Therapeutics Inc.

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 11.7%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 101.5%

Abeona Therapeutics Inc. Technicals Summary

Sell

Neutral

Buy

Abeona Therapeutics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Abeona Therapeutics Inc. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Abeona Therapeutics Inc.	0.96%	40.87%	26.63%	-62.06%	-91.82%
Regeneron Pharmaceuticals, Inc.	-5.97%	-23.44%	-9.57%	20.91%	110.02%
Biontech Se	11.44%	18.44%	16.6%	-60.74%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.77%	64.82%	42.06%	39.68%	108.61%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.79%	29.94%	124.11%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Abeona Therapeutics Inc.	0.06	NA	0.0	-1.56	-1.27	-0.38	NA	0.56
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Abeona Therapeutics Inc.	Buy	$261.3M	-91.82%	0.06	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Abeona Therapeutics Inc.

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t

Organization	Abeona Therapeutics Inc.
Employees	84
CEO	Dr. Vishwas Seshadri M.B.A., Ph.D.
Industry	Health Technology

Management People of Abeona Therapeutics Inc.

Name	Title
Dr. Vishwas Seshadri M.B.A., Ph.D.	President, CEO & Director
Mr. Brian Kevany Ph.D.	Senior VP, CTO & CSO
Mr. Gregory Gin	Vice President of Investor Relations & Corporate Communications
Ms. Alison Hardgrove	Chief People Officer
Mr. Jon Voss	VP & Head of Quality
Dr. Madhav Vasanthavada M.B.A., Ph.D.	Senior VP, Chief Commercial Officer & Head of Business Development
Mr. Carl Denny	Senior Vice President of Regulatory Affairs

Important FAQs about investing in Abeona Therapeutics Inc. from India :

What is Abeona Therapeutics Inc. share price today?

Abeona Therapeutics Inc. (ABEO) share price today is $6.02.

Can Indians buy Abeona Therapeutics Inc. shares?

Yes, Indians can invest in the Abeona Therapeutics Inc. (ABEO) from India.

With INDmoney, you can buy Abeona Therapeutics Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Abeona Therapeutics Inc. at zero transaction cost.

How can I buy Abeona Therapeutics Inc. shares from India?

It is very easy to buy Abeona Therapeutics Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abeona Therapeutics Inc. be purchased?

Yes, you can buy fractional shares of Abeona Therapeutics Inc. with INDmoney app.

What are the documents required to start investing in Abeona Therapeutics Inc. stocks?

To start investing in Abeona Therapeutics Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.